Exact Sciences
Stock Forecast, Prediction & Price Target
Exact Sciences (EXAS) stock Price Target by analysts
$78.63
Potential upside: 69.41%
Exact Sciences price prediction
What is Exact Sciences stock analysts` prediction?
Exact Sciences stock forecast: Based on 6 Wall Street analysts` predicted price targets for Exact Sciences in the last 3 months, the avarage price target is $78.63, with a high forecast of $NaN. The average price target represents a 69.41% change from the last price of $46.41.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Exact Sciences stock Price Target by analysts
Full breakdown of analysts given Exact Sciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Catherine Schulte Robert W. Baird | 50% 1/2 | 10 months ago | $67 44.36% upside | $72.42 | StreetInsider | Previous targets (1) |
Mark Massaro BTIG | 0% 0/3 | 10 months ago | $65 40.05% upside | $72.42 | StreetInsider | Previous targets (2) |
Kyle Mikson Canaccord Genuity | 0% 0/3 | 10 months ago | $95 104.69% upside | $69.35 | StreetInsider | Previous targets (2) |
Vijay Kumar Evercore ISI | 0% 0/2 | 11 months ago | $80 72.37% upside | $68.12 | TheFly | Previous targets (1) |
Mark Massaro BTIG | 0% 0/3 | 12 months ago | $82 76.68% upside | $69.48 | TheFly | Previous targets (2) |
Patrick Donnelly Citigroup | 0% 0/2 | 12 months ago | $80 72.37% upside | $67.9 | StreetInsider | Previous targets (1) |
Kyle Mikson Canaccord Genuity | 0% 0/3 | 12 months ago | $75 61.60% upside | $67.39 | StreetInsider | Previous targets (2) |
David Westenberg Piper Sandler | 33.33% 1/3 | 12 months ago | $85 83.15% upside | $66.93 | StreetInsider | Previous targets (2) |
David Westenberg Piper Sandler | 33.33% 1/3 | about 1 year ago | $80 72.37% upside | $46.81 | StreetInsider | Previous targets (2) |
Mark Massaro BTIG | 0% 0/3 | about 1 year ago | $70 50.82% upside | $41.37 | TheFly | Previous targets (2) |
Sung Ji Nam Scotiabank | 0% 0/1 | about 1 year ago | $70 50.82% upside | $44.16 | TheFly | Previous targets (0) |
Tycho Peterson Jefferies | 0% 0/1 | over 1 year ago | $75 61.60% upside | $45.45 | TheFly | Previous targets (0) |
Kyle Mikson Canaccord Genuity | 0% 0/3 | over 1 year ago | $85 83.15% upside | $59.48 | TheFly | Previous targets (2) |
Patrick Donnelly Citigroup | 0% 0/2 | about 2 years ago | $130 180.11% upside | $94.58 | Benzinga | Previous targets (1) |
Matthew Sykes Goldman Sachs | 50% 1/2 | over 2 years ago | $65 40.05% upside | $55.2 | TheFly | Previous targets (1) |
David Westenberg Piper Sandler | 33.33% 1/3 | about 3 years ago | $40 -13.81% downside | $39.56 | TheFly | Previous targets (2) |
Catherine Schulte Robert W. Baird | 50% 1/2 | about 3 years ago | $75 61.60% upside | $43.61 | Pulse 2.0 | Previous targets (1) |
Unknown Craig-Hallum | N/A | about 3 years ago | $60 29.28% upside | $46.95 | Benzinga | N/A |
Unknown BTIG | N/A | about 3 years ago | $70 50.82% upside | $46.2 | Benzinga | N/A |
Andrew Cooper Raymond James | 100% 1/1 | over 3 years ago | $80 72.37% upside | $55.67 | Pulse 2.0 | Previous targets (0) |
Brandon Couillard Jefferies | 0% 0/1 | over 3 years ago | $140 201.65% upside | $76.13 | TipRanks Contributor | Previous targets (0) |
Daniel Arias Stifel Nicolaus | 0% 0/1 | almost 4 years ago | $125 169.33% upside | $94.32 | StreetInsider | Previous targets (0) |
Daniel Brennan Cowen & Co. | 0% 0/1 | almost 4 years ago | $135 190.88% upside | $97.75 | TheFly | Previous targets (0) |
Kyle Mikson CFA Canaccord Genuity | 0% 0/1 | almost 4 years ago | $160 244.75% upside | $104.65 | TheFly | Previous targets (0) |
Vijay Kumar Evercore ISI | 0% 0/2 | about 4 years ago | $145 212.43% upside | $104.21 | TheFly | Previous targets (1) |
Matthew Sykes Goldman Sachs | 50% 1/2 | over 4 years ago | $160 244.75% upside | $107.91 | TheFly | Previous targets (1) |
Sandy Draper Guggenheim | 0% 0/1 | over 4 years ago | $168 261.99% upside | $96.11 | TheFly | Previous targets (0) |
Exact Sciences Financial Estimates
Exact Sciences Revenue Estimates
Exact Sciences EBITDA Estimates
Exact Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.76B N/A | $2.08B 17.94% | $2.49B 19.93% | Avg: $3.21B Low: $3.17B High: $3.24B avg. 28.69% | Avg: $3.61B Low: $3.58B High: $3.66B avg. 12.51% | Avg: $3.89B Low: $3.85B High: $3.93B avg. 7.53% | Avg: $4.09B Low: $4.04B High: $4.13B avg. 5.09% |
Net Income
% change YoY
| $-595.62M N/A | $-623.50M -4.68% | $-204.14M 67.25% | Avg: $-34.82M Low: $-126.10M High: $86.46M avg. 82.94% | Avg: $123.91M Low: $23.41M High: $385.50M avg. 455.85% | Avg: $163.74M Low: $161.58M High: $166.25M avg. 32.14% | Avg: $226.08M Low: $223.09M High: $229.54M avg. 38.06% |
EBITDA
% change YoY
| $-740.46M N/A | $-480.09M 35.16% | $41.87M 108.72% | Avg: $-781.66M Low: $-788.96M High: $-771.92M avg. -1966.61% | Avg: $-879.48M Low: $-889.85M High: $-870.56M avg. -12.51% | Avg: $-945.77M Low: $-956.92M High: $-936.17M avg. -7.53% | Avg: $-993.93M Low: $-1.00B High: $-983.85M avg. -5.09% |
EPS
% change YoY
| -$3.48 N/A | -$3.54 -1.72% | -$1.13 68.07% | Avg: -$0.14 Low: -$0.7 High: $0.48 avg. 87.69% | Avg: $0.77 Low: $0.13 High: $2.14 avg. 650.39% | Avg: $0.91 Low: $0.9 High: $0.92 avg. 18.76% | Avg: $1.26 Low: $1.24 High: $1.27 avg. 38.06% |
Operating Expenses
% change YoY
| $2.14B N/A | $2.08B -2.62% | $2.06B -1.28% | Avg: $2.51B Low: $2.48B High: $2.53B avg. 22.07% | Avg: $2.83B Low: $2.80B High: $2.86B avg. 12.51% | Avg: $3.04B Low: $3.01B High: $3.07B avg. 7.53% | Avg: $3.19B Low: $3.16B High: $3.23B avg. 5.09% |
FAQ
What is Exact Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 152.25% in 2025-2028.
We have gathered data from 12 analysts. Their low estimate is -126.10M, average is -34.82M and high is 86.46M.
What is Exact Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 13.45% in 2025-2028.
We have gathered data from 17 analysts. Their low revenue estimate is $3.17B, average is $3.21B and high is $3.24B.
What is Exact Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 198.72% in 2025-2028.
We have gathered data from 12 analysts. Their low earnings per share estimate is -$0.7, average is -$0.14 and high is $0.48.
What is the best performing analyst?
In the last twelve months 6 analysts have been covering Exact Sciences stock. The most successful analyst is Catherine Schulte whose win rate is 50%. He has correctly predicted 1/2 price targets.